• OPEN AN ACCOUNT
Indian Indices
Sensex
78,954.76 373.76
( 0.48%)
Global Indices
Nasdaq
54,370.92 264.04
(0.49%)
Dow Jones
7,742.03 -15.49
(-0.20%)
Hang Seng
65,663.80 -636.64
(-0.96%)
Nikkei 225
10,894.52 15.14
(0.14%)
Forex
USD-INR
95.23 -0.06
(-0.07%)
EUR-INR
109.68 -0.11
(-0.10%)
GBP-INR
127.98 -0.19
(-0.15%)
JPY-INR
0.60 0.00
(-0.60%)

EQUITY - MARKET SCREENER

Vivimed Labs Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
532660
INE526G01021
-18.1148384
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
VIVIMEDLAB
0
42.45
EPS(TTM)
Face Value()
Div & Yield %
0
2
0
 

Indo Amines consolidated net profit rises 73.08% in the March 2026 quarter
May 27,2026
Net profit of Indo Amines rose 73.08% to Rs 20.51 crore in the quarter ended March 2026 as against Rs 11.85 crore during the previous quarter ended March 2025. Sales rose 11.28% to Rs 317.61 crore in the quarter ended March 2026 as against Rs 285.41 crore during the previous quarter ended March 2025.

For the full year,net profit rose 41.91% to Rs 79.33 crore in the year ended March 2026 as against Rs 55.90 crore during the previous year ended March 2025. Sales rose 7.51% to Rs 1159.66 crore in the year ended March 2026 as against Rs 1078.68 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales317.61285.41 11 1159.661078.68 8
OPM %10.778.69 -10.599.37 -
PBDT34.4619.42 77 127.6093.99 36
PBT28.6715.25 88 106.1176.94 38
NP20.5111.85 73 79.3355.90 42